Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2024
About
Suggestions
Contact Us
Heparin Antagonists
MeSH Descriptor Data 2025
Details
Qualifiers
MeSH Tree Structures
Concepts
MeSH Heading
Heparin Antagonists
Tree Number(s)
D27.505.519.452
D27.505.954.502.270.546
Unique ID
D006494
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D006494
Scope Note
Coagulant substances inhibiting the anticoagulant action of heparin.
Entry Version
HEPARIN ANTAG
Date Established
1966/01/01
Date of Entry
1999/01/01
Revision Date
2014/06/25
Allowable Qualifiers
administration & dosage (AD)
adverse effects (AE)
analysis (AN)
blood (BL)
cerebrospinal fluid (CF)
chemical synthesis (CS)
chemistry (CH)
classification (CL)
economics (EC)
history (HI)
immunology (IM)
isolation & purification (IP)
metabolism (ME)
pharmacokinetics (PK)
pharmacology (PD)
poisoning (PO)
radiation effects (RE)
standards (ST)
supply & distribution (SD)
therapeutic use (TU)
toxicity (TO)
urine (UR)
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Molecular Mechanisms of Pharmacological Action [D27.505.519]
Alkylating Agents [D27.505.519.124]
Amylin Receptor Agonists [D27.505.519.143]
Angiotensin Receptor Antagonists [D27.505.519.162]
Antacids [D27.505.519.170]
Antidiuretic Hormone Receptor Antagonists [D27.505.519.174]
Antifoaming Agents [D27.505.519.178]
Antiglycation Agents [D27.505.519.182]
Antimetabolites [D27.505.519.186]
Antioxidants [D27.505.519.217]
Aversive Agents [D27.505.519.241]
Bradykinin Receptor Antagonists [D27.505.519.265]
Calcitonin Gene-Related Peptide Receptor Antagonists [D27.505.519.270]
CCR5 Receptor Antagonists [D27.505.519.275]
Cerumenolytic Agents [D27.505.519.295]
Cystine Depleting Agents [D27.505.519.334]
Cytochrome P-450 Enzyme Inducers [D27.505.519.349]
Endothelin Receptor Antagonists [D27.505.519.364]
Enzyme Activators [D27.505.519.374]
Enzyme Inhibitors [D27.505.519.389]
Enzyme Reactivators [D27.505.519.405]
Fibrin Modulating Agents [D27.505.519.421]
Heparin Antagonists [D27.505.519.452]
Immune Checkpoint Inhibitors [D27.505.519.507]
Membrane Transport Modulators [D27.505.519.562]
Mitosis Modulators [D27.505.519.593]
Neurotransmitter Agents [D27.505.519.625]
Nitric Oxide Donors [D27.505.519.656]
Peptidomimetics [D27.505.519.828]
Radiopharmaceuticals [D27.505.519.871]
Sequestering Agents [D27.505.519.914]
Sodium-Glucose Transporter 2 Inhibitors [D27.505.519.936]
Sphingosine 1 Phosphate Receptor Modulators [D27.505.519.947]
Toll-Like Receptor Agonists [D27.505.519.952]
Viral Fusion Protein Inhibitors [D27.505.519.957]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Hematologic Agents [D27.505.954.502]
Coagulants [D27.505.954.502.270]
Agglutinins [D27.505.954.502.270.232]
Hemostatics [D27.505.954.502.270.463]
Heparin Antagonists [D27.505.954.502.270.546]
Expand All
Collapse All
Heparin Antagonists
Preferred
Concept UI
M0010190
Scope Note
Coagulant substances inhibiting the anticoagulant action of heparin.
Terms
Heparin Antagonists
Preferred Term
Term UI
T019586
Date
01/01/1999
LexicalTag
NON
ThesaurusID
NLM (1966)
page delivered in 0.168s